Early research (Phase 1)Active Not RecruitingNCT06335849
What this trial is testing
A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine (CHO Cell), LYB004 in Adults Aged 50 to 70 Years
Who this might be right for
Herpes Zoster
Guangzhou Patronus Biotech Co., Ltd. 48